This study investigates the association between liver fibrosis and diabetic peripheral neuropathy (DPN) in patients with type ...
Fatty liver cases are rising due to lifestyle and diet habits. Experts explain common myths, early signs and everyday ...
A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and ...
LFT slightly high. There is no pain. No yellowing of the eyes. No weakness. So it is easy to brush it aside. But the liver rarely shouts in the beginning. It whispers.Liver Function Tests, or LFTs, ...
In its 250th year, is America, land of immigration, becoming a country of emigration? Last year the U.S. experienced something that hasn’t definitively occurred since the Great Depression: More people ...
Dec 19 (Reuters) - Altimmune (ALT.O), opens new tab said on Friday its experimental liver disease drug led to weight loss and improved markers for scarring and health of the organ based on ...
Altimmune Inc. (NASDAQ: ALT) on Friday shared topline results from the IMPACT Phase 2b trial of pemvidutide. Patients had metabolic dysfunction-associated steatohepatitis (MASH) at 48 weeks. MASH is a ...
Shares of Altimmune rose on positive trial results for its treatment for metabolic dysfunction-associated steatohepatitis, or MASH, a liver disease. The stock climbed 7.5% to $5.43 in premarket ...
Shares of Cogent Biosciences (COGT) climbed ~120% in the premarket on Monday after the company disclosed encouraging late-stage trial data for its lead asset, bezuclastinib, against a form of ...
Curcuma longa, which contains curcumin as a major constituent, has been shown many pharmacological effects, but it is limited using in clinical due to low bioavailability. In this study, we developed ...
Elevated liver enzymes can indicate a problem in the liver. However, eating a balanced diet and regularly exercising are some of the ways a person can lower liver enzyme levels. The liver contains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results